Key result
Atenolol reduces exercise heart rate by ~30% vs placebo in young hypertensive patients.
Why the study?
The influence of chronic β1‐adrenoceptor blockade on haemodynamic and metabolic responses during prolonged submaximal exercise in hypertensive patients was not fully understood.
RCT (n=8)
Randomly allocated
Reduces leg blood flow and fat use during submaximal exercise in young hypertensives; leaves open effects on endurance or outcomes.
Summary The influence of chronic β1‐adrenoceptor blockade on haemodynamic and metabolic responses was examined in eight young hypertensive subjects during a 40 min submaximal bicycle test at 50% of maximal capacity. The patients were randomly allocated to one placebo and one treatment period of 6 weeks. During treatment atenolol (Tenormin, 100 mg) was given twice daily. Arterial pressure, cardiac output, leg blood flow, oxygen uptake and different metabolites in the blood were determined. The heart rate was reduced by β1‐adrenoceptor blockade by 30% during exercise, and the decrease was related to plasma concentration of the drug. Cardiac output was decreased by approximately 10%, but the negative chronotropic effect was partly compensated for by a higher stroke volume. Blockade leg blood flow was reduced by 10%, but more oxygen was extracted, giving an unchanged oxygen uptake. Blood concentration and leg uptake of glucose were not influenced by the treatment, but plasma free fatty acids were reduced by 30‐40%. Leg lactate release was decreased to half the value in the unblocked situation. Plasma renin activity did not increase at the beginning of exercise, but after 40 min an increase was seen, though only to half of the pretreatment value. It is concluded that β1‐adrenoceptor blockade during submaximal exercise reduces blood flow to the working muscles and that this reduction is the result of a lower cardiac output. Aerobic metabolism is unchanged as a result of increased oxygen extraction, but less fat is used as lipolysis is inhibited. Glucose uptake by the working muscles is unchanged by β1‐blockade, but there is evidence for an increased carbohydrate metabolism. As for non‐selective blockade, atenolol decreases lactate release but this could be the result of non‐specific action on the β1‐reccptor and/or increased carbohydrate oxidation. Furthermore, the β1‐adrcnoceptors seem to have a major influence on the renin release during exercise.
No takes yet. Share an insight, caveat, or question.
Frisk‐Holmberg et al. (1985) conducted an RCT in Hypertension (n=8). Atenolol (Tenormin) vs. Placebo was evaluated on Haemodynamic and metabolic responses during submaximal exercise. Six weeks of atenolol treatment in young hypertensive subjects reduced heart rate by 30%, cardiac output by 10%, and leg blood flow by 10% during submaximal exercise compared to placebo.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: